Ackman Says Allergan Sale May Net $6B For Pershing Square
Bill Ackman said that his Pershing Square Capital Management LP could realize $6 billion when pharmaceutical company Allergan Inc. closes its sale to rival Actavis PLC, after his pressure led to...To view the full article, register now.
Already a subscriber? Click here to view full article